{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T03:17:41Z","timestamp":1789615061906,"version":"build-2803163510"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,5,17]],"date-time":"2018-05-17T00:00:00Z","timestamp":1526515200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s12325-018-0711-3","type":"journal-article","created":{"date-parts":[[2018,5,17]],"date-time":"2018-05-17T08:59:15Z","timestamp":1526547555000},"page":"779-784","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Application of Cu-64 NODAGA-PSMA PET in Prostate Cancer"],"prefix":"10.1007","volume":"35","author":[{"given":"Sabina","family":"Sevcenco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans Christoph","family":"Klingler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3676-5262","authenticated-orcid":false,"given":"Klaus","family":"Eredics","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Friedl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenifer","family":"Schneeweiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Knoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kunit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Lusuardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siroos","family":"Mirzaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,17]]},"reference":[{"issue":"1","key":"711_CR1","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.eururo.2013.09.046","volume":"65","author":"A Heidenreich","year":"2014","unstructured":"Heidenreich A, Bastian PJ, Bellmunt J, Bolla M, Joniau S, et al. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent-update 2013. Eur Urol. 2014;65(1):124\u201337.","journal-title":"Eur Urol"},{"issue":"16","key":"711_CR2","first-page":"30160","volume":"S2405\u20134569","author":"FE Eyben von","year":"2016","unstructured":"von Eyben FE, Picchio M, von Eyben R et al., 68Ga-labeled prostate-specific membrane antigen ligand positron emission tomography\/computed tomography for prostate cancer: a systematic review and meta-analysis. Eur Urol Focus. 2016;S2405\u20134569(16)30160\u20132.","journal-title":"Eur Urol Focus"},{"issue":"8","key":"711_CR3","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.2967\/jnumed.115.160382","volume":"56","author":"JJ Morigi","year":"2015","unstructured":"Morigi JJ, Stricker PD, van Leeuwen PJ, Tang R, et al. Prospective comparison of 18F-fluoromethylcholine versus 68Ga-PSMA PET\/CT in prostate cancer patients who have rising PSA after curative treatment and are being considered for targeted therapy. J Nucl Med. 2015;56(8):1185\u201390.","journal-title":"J Nucl Med"},{"issue":"12","key":"711_CR4","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.7150\/thno.13348","volume":"5","author":"S Lutje","year":"2015","unstructured":"Lutje S, Heskamp S, Cornelissen AS, et al. PSMA ligands for radionuclide imaging and therapy of prostate cancer: clinical status. Theranostics. 2015;5(12):1388\u2013401.","journal-title":"Theranostics"},{"issue":"11","key":"711_CR5","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.2967\/jnumed.116.173492","volume":"57","author":"I Rauscher","year":"2016","unstructured":"Rauscher I, Maurer T, Beer AJ, et al. Value of 68Ga-PSMA HBED-CC PET for the assessment of lymph node metastases in prostate cancer patients with biochemical recurrence: comparison with histopathology after salvage lymphadenectomy. J Nucl Med. 2016;57(11):1713\u20139.","journal-title":"J Nucl Med"},{"issue":"5","key":"711_CR6","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1021\/cr900325h","volume":"110","author":"TJ Wadas","year":"2010","unstructured":"Wadas TJ, Wong EH, Weisman GR, et al. Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease. Chem Rev. 2010;110(5):2858\u2013902.","journal-title":"Chem Rev"},{"issue":"6","key":"711_CR7","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1021\/acs.molpharmaceut.6b00143","volume":"13","author":"R Farkas","year":"2016","unstructured":"Farkas R, Siwowska K, Ametamey SM, et al. (64)Cu- and (68)Ga-based PET imaging of folate receptor-positive tumors: development and evaluation of an albumin-binding NODAGA-folate. Mol Pharm. 2016;13(6):1979\u201387.","journal-title":"Mol Pharm"},{"key":"711_CR8","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1089\/cbr.2015.1964","volume":"31","author":"B Grubm\u00fcller","year":"2016","unstructured":"Grubm\u00fcller B, Baum RP, Capasso E, et al. 64Cu-PSMA-617 PET\/CT imaging of prostate adenocarcinoma: first in-human studies. Cancer Biother Radiopharm. 2016;31:277\u201386.","journal-title":"Cancer Biother Radiopharm"},{"issue":"2","key":"711_CR9","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.nucmedbio.2014.09.009","volume":"42","author":"SC Ghosh","year":"2015","unstructured":"Ghosh SC, Pinkston KL, Robinson H, et al. Comparison of DOTA and NODAGA as chelators for (64)Cu-labeled immunoconjugates. Nucl Med Biol. 2015;42(2):177\u201383.","journal-title":"Nucl Med Biol"},{"issue":"1","key":"711_CR10","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.eururo.2016.01.029","volume":"70","author":"L Evangelista","year":"2016","unstructured":"Evangelista L, Briganti A, Fanti S, et al. New clinical indications for (18)F\/(11)C-choline, new tracers for Positron Emission Tomography and a Promising Hybrid Device for prostate cancer staging: a systematic review of the literature. Eur Urol. 2016;70(1):161\u201375.","journal-title":"Eur Urol"},{"issue":"3","key":"711_CR11","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2174\/18744710113069990020","volume":"6","author":"L Evangelista","year":"2013","unstructured":"Evangelista L, Luigi M, Cascini GL. New issues for copper-64: from precursor to innovative PET tracers in clinical oncology. Curr Radiopharm. 2013;6(3):117\u201323.","journal-title":"Curr Radiopharm"},{"issue":"12","key":"711_CR12","doi-asserted-by":"publisher","first-page":"e0145755","DOI":"10.1371\/journal.pone.0145755","volume":"10","author":"E Gourni","year":"2015","unstructured":"Gourni E, Canovas C, Goncalves V, et al. (R)-NODAGA-PSMA: a versatile precursor for radiometal labeling and nuclear imaging of PSMA-positive tumors. PLoS ONE. 2015;10(12):e0145755.","journal-title":"PLoS ONE"},{"key":"711_CR13","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.urology.2017.04.019","volume":"106","author":"F Cantiello","year":"2017","unstructured":"Cantiello F, Gangemi V, Cascini GL, et al. Diagnostic accuracy of 64Copper prostate-specific membrane antigen positron emission tomography\/computed tomography for primary lymph node staging of intermediate- to high-risk prostate cancer: our preliminary experience. Urology. 2017;106:139\u201345.","journal-title":"Urology"},{"issue":"2","key":"711_CR14","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s00259-014-2949-6","volume":"42","author":"A Afshar-Oromieh","year":"2015","unstructured":"Afshar-Oromieh A, Avtzi E, Giesel FL, et al. The diagnostic value of PET\/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer. Euro J Nucl Med Mol Imaging. 2015;42(2):197\u2013209.","journal-title":"Euro J Nucl Med Mol Imaging"},{"issue":"11","key":"711_CR15","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.nucmedbio.2016.08.006","volume":"43","author":"MRA Pillai","year":"2016","unstructured":"Pillai MRA, Nanabala R, Joy A, et al. Radiolabeled enzyme inhibitors and binding agents targeting PSMA: effective theranostic tools for imaging and therapy of prostate cancer. Nucl Med Biol. 2016;43(11):692\u2013720.","journal-title":"Nucl Med Biol"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12325-018-0711-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-018-0711-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-018-0711-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T19:15:47Z","timestamp":1558034147000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12325-018-0711-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,17]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["711"],"URL":"https:\/\/doi.org\/10.1007\/s12325-018-0711-3","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,17]]},"assertion":[{"value":"30 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2018","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}